Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
62.7 USD | -2.07% | -3.89% | -24.87% |
May. 09 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
May. 08 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated